FDA orphan drug designation: treatment of multiple myeloma
All entries for: BrightPath Biotherapeutics Co. Ltd.
July 2, 2025
BrightPath Biotherapeutics Co. Ltd.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of multiple myeloma
